Skip to main content
Advertisement
Advertisement
LLY
LLY logo
Eli Lilly & Co.
1,432.29
USD
Sponsored
+20.34
+1.44%
Nov 10, 15:59 UTC -5
Closed
exchange

Pre-Market

1,414.75

-17.54
-1.22%

Eli Lilly & Co. (LLY) Earnings

LLY Earnings Reports

Positive Surprise Ratio

LLY beat 31 of 43 last estimates.

72%

Next Report

Date of Next Report
Feb 02, 2027
Estimate for Q4 26 (Revenue/ EPS)
$24.84B
/
$11.28
Implied change from Q3 26 (Revenue/ EPS)
+1.83%
/
+50.80%
Implied change from Q4 25 (Revenue/ EPS)
+28.77%
/
+49.60%

Eli Lilly & Co. earnings per share and revenue

On Oct 29, 2026, LLY reported earnings of 7.48 USD per share (EPS) for Q3 26, beating the estimate of 6.32 USD, resulting in a 18.32% surprise. Revenue reached 24.40 billion, compared to an expected 22.84 billion, with a 6.84% difference. The market reacted with a +6.63% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 11.28 USD, with revenue projected to reach 24.84 billion USD, implying an increase of 50.80% EPS, and increase of 1.83% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
ABBVIE INC.
Report Date
Oct 30, 2026 For Q3 26
Estimate
$3.82
Actual
$3.82
Surprise
-0.08%
logo
Merck & Co., Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$2.10
Actual
$2.49
Surprise
+18.46%
logo
Novo-Nordisk A/S
Report Date
Nov 04, 2026 For Q3 26
Estimate
$4.86
Actual
$3.79
Surprise
-22.10%
logo
Pfizer Inc.
Report Date
Nov 03, 2026 For Q3 26
Estimate
$0.73
Actual
$0.87
Surprise
+17.58%
logo
Sanofi - ADR
Report Date
Oct 30, 2026 For Q3 26
Estimate
$2.79
Actual
$3.55
Surprise
+26.80%
logo
Innoviva, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.52
Actual
-$1.03
Surprise
-296.08%
FAQ
For Q3 2026, Eli Lilly & Co. reported EPS of $7.48, beating estimates by 18.32%, and revenue of $24.40B, 6.84% above expectations.
The stock price moved up 6.63%, changed from $1.29K before the earnings release to $1.37K the day after.
The next earning report is scheduled for Feb 02, 2027.
Based on -- analysts, Eli Lilly & Co. is expected to report EPS of $11.28 and revenue of $24.84B for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement